T-Epivaccines Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
T-Epivaccines General Information
Description
Provider of a cancer therapy based in France. The company develops immunotherapy for lungs and prostate cancer.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
- France
Primary Industry
Other Healthcare Services
Vertical(s)
Life Sciences,
Oncology
Corporate Office
- France
T-Epivaccines Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
T-Epivaccines Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
T-Epivaccines Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Institut Pasteur | Accelerator/Incubator | 000 0000 | 000000 0 |
T-Epivaccines FAQs
-
Where is T-Epivaccines headquartered?
T-Epivaccines is headquartered in France.
-
What industry is T-Epivaccines in?
T-Epivaccines’s primary industry is Other Healthcare Services.
-
Is T-Epivaccines a private or public company?
T-Epivaccines is a Private company.
-
What is T-Epivaccines’s current revenue?
The current revenue for T-Epivaccines is 000000.
-
Who are T-Epivaccines’s investors?
The Institut Pasteur has invested in T-Epivaccines.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
